Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatitis B × tenofovir alafenamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Tenofovir 3 entecavir 2 tenofovir alafenamide 1 human papillomavirus vaccine, L1 type 16, 18 1 Standard of Care 1 Practice Guidelines as Topic 1 Lamivudine 1 Engerix-B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

SWOG Cancer Research Network

Phase 3 Terminated

4 enrolled 5 charts

Hepatitis B

Data powered by HemOnc (CC BY 4.0) Colophon ⚡